HIV silencing and cell survival signatures in infected T cell reservoirs
暂无分享,去创建一个
A. Abate | E. Boritz | D. Douek | F. Quintana | S. Darko | Michael A. Wheeler | S. Deeks | Amy R. Henry | I. Clark | R. Hoh | Divya Kilam | Salwan Butrus | D. Bunis | Sung Hee Ko | P. Mudvari | M. Abu-Laban | S. Thaploo | L. Pérez | James S. Lee | Samuel Smith | Mehdi Hamouda | Marc Theberge | Sakshi Shah | Saami Zakaria | Sally Choi | S. Ko | Samuel G. Smith | Sally Choi | Marc W Theberge | Samuel G Smith | Shravan Thaploo
[1] A. Abate,et al. Identification of astrocyte regulators by nucleic acid cytometry , 2023, Nature.
[2] M. Churchill,et al. Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART , 2022, Annals of neurology.
[3] M. Nussenzweig,et al. Distinct gene expression by expanded clones of quiescent memory CD4+ T cells harboring intact latent HIV-1 proviruses , 2022, bioRxiv.
[4] L. Montaner,et al. Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones. , 2022, Immunity.
[5] R. Siliciano,et al. In Vivo Dynamics of the Latent Reservoir for HIV-1: New Insights and Implications for Cure. , 2021, Annual review of pathology.
[6] Samantha D. Drinan,et al. Intragenic proviral elements support transcription of defective HIV-1 proviruses , 2021, bioRxiv.
[7] D. Kaufmann,et al. Combined single-cell transcriptional, translational, and genomic profiling reveals HIV-1 reservoir diversity. , 2021, Cell reports.
[8] R. Zurakowski,et al. Naive infection predicts reservoir diversity and is a formidable hurdle to HIV eradication , 2021, JCI insight.
[9] Xiaochen Bo,et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.
[10] R. Siliciano,et al. Antigen-driven clonal selection shapes the persistence of HIV-1 infected CD4+ T cells in vivo , 2020, bioRxiv.
[11] Deqing Hu,et al. Competition between PAF1 and MLL1/COMPASS confers the opposing function of LEDGF/p75 in HIV latency and proviral reactivation , 2020, Science Advances.
[12] M. Nussenzweig,et al. Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir , 2020, bioRxiv.
[13] A. Stukalov,et al. The alternative cap-binding complex is required for antiviral defense in vivo , 2019, PLoS pathogens.
[14] N. Wu,et al. Retinoblastoma binding protein 4 represses HIV-1 long terminal repeat-mediated transcription by recruiting NR2F1 and histone deacetylase. , 2019, Acta biochimica et biophysica Sinica.
[15] Rosa M. Badia,et al. Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations , 2019, PLoS pathogens.
[16] Miklós Emri,et al. Analysis of networks of host proteins in the early time points following HIV transduction , 2019, BMC Bioinformatics.
[17] M. Tremblay,et al. Host mRNA decay proteins influence HIV-1 replication and viral gene expression in primary monocyte-derived macrophages , 2019, Retrovirology.
[18] A. Abate,et al. Microfluidic bead encapsulation above 20 kHz with triggered drop formation† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8lc00514a , 2018, Lab on a chip.
[19] M. Nussenzweig,et al. Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation , 2018, Nature Medicine.
[20] J. Wong,et al. HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing , 2018, Science Translational Medicine.
[21] W. Paxton,et al. Blood CXCR3+ CD4 T Cells Are Enriched in Inducible Replication Competent HIV in Aviremic Antiretroviral Therapy-Treated Individuals , 2018, Front. Immunol..
[22] Astrid Gall,et al. Easy and accurate reconstruction of whole HIV genomes from short-read sequence data with shiver , 2018, Virus evolution.
[23] E. Boritz,et al. Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants. , 2017, Cell reports.
[24] Nancie M Archin,et al. Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency , 2017, The Journal of clinical investigation.
[25] E. Rosenberg,et al. Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells , 2017, The Journal of clinical investigation.
[26] Geet Duggal,et al. Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference , 2017, Nature Methods.
[27] B. Walker,et al. Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals. , 2016, Cell host & microbe.
[28] S. Hughes,et al. Multiple Origins of Virus Persistence during Natural Control of HIV Infection , 2016, Cell.
[29] G. Pantaleo,et al. PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals , 2016, Nature Medicine.
[30] Andrew D. Rouillard,et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..
[31] M. Altfeld,et al. Follicular Dendritic Cells Retain Infectious HIV in Cycling Endosomes , 2015, PLoS pathogens.
[32] S. Gordon,et al. G3BP1 restricts HIV-1 replication in macrophages and T-cells by sequestering viral RNA. , 2015, Virology.
[33] Rebecca Hoh,et al. Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study. , 2015, The lancet. HIV.
[34] G. Pantaleo,et al. The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo , 2015, PLoS pathogens.
[35] D. Hazuda,et al. A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals , 2015, EBioMedicine.
[36] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[37] Sarah Palmer,et al. Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial. , 2014, The lancet. HIV.
[38] Joakim Lundeberg,et al. Sequencing Degraded RNA Addressed by 3' Tag Counting , 2014, PloS one.
[39] Andreas Krämer,et al. Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..
[40] Sarah B. Laskey,et al. Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.
[41] Åsa K. Björklund,et al. Smart-seq2 for sensitive full-length transcriptome profiling in single cells , 2013, Nature Methods.
[42] Nan Li,et al. LRRFIP2 negatively regulates NLRP3 inflammasome activation in macrophages by promoting Flightless-I-mediated caspase-1 inhibition , 2013, Nature Communications.
[43] Xin Zhou,et al. Involvement of histone methyltransferase GLP in HIV-1 latency through catalysis of H3K9 dimethylation. , 2013, Virology.
[44] E. Chen,et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.
[45] T. Chun,et al. Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy. , 2012, The Journal of infectious diseases.
[46] J. Eron,et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy , 2012, Nature.
[47] T. Ludwig,et al. Contact-Dependent T Cell Activation and T Cell Stopping Require Talin1 , 2011, The Journal of Immunology.
[48] C. B. Hare,et al. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. , 2010, The Journal of infectious diseases.
[49] J. Routy,et al. Peripheral Blood CCR4+CCR6+ and CXCR3+CCR6+ CD4+ T Cells Are Highly Permissive to HIV-1 Infection , 2009, The Journal of Immunology.
[50] Davis J. McCarthy,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[51] Geneviève Boucher,et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation , 2009, Nature Medicine.
[52] N. Hogg,et al. Guanine nucleotide-binding proteins of the G12 family shape immune functions by controlling CD4+ T cell adhesiveness and motility. , 2009, Immunity.
[53] S. Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[54] I. Sadowski,et al. Specific interaction of TFII‐I with an upstream element on the HIV‐1 LTR regulates induction of latent provirus , 2008, FEBS letters.
[55] E. Paskaleva,et al. BCL11B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complex. , 2008, Virology.
[56] B. Berkhout,et al. Highly Sensitive Methods Based on Seminested Real-Time Reverse Transcription-PCR for Quantitation of Human Immunodeficiency Virus Type 1 Unspliced and Multiply Spliced RNA and Proviral DNA , 2008, Journal of Clinical Microbiology.
[57] L. Davis,et al. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. , 2008, Immunity.
[58] D. Price,et al. Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR , 2007, Nucleic acids research.
[59] Qiang Zhou,et al. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription , 2007, Nucleic acids research.
[60] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[61] Loni Pickle,et al. A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat. , 2005, Genes & development.
[62] Mario Roederer,et al. T-Cell Subsets That Harbor Human Immunodeficiency Virus (HIV) In Vivo: Implications for HIV Pathogenesis , 2004, Journal of Virology.
[63] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[64] E. Verdin,et al. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro , 2003, The EMBO journal.
[65] Z. Grossman,et al. HIV preferentially infects HIV-specific CD4+ T cells , 2002, Nature.
[66] A. Rice,et al. Induction of TAK (Cyclin T1/P-TEFb) in Purified Resting CD4+ T Lymphocytes by Combination of Cytokines , 2001, Journal of Virology.
[67] J. Steitz,et al. Communication of the Position of Exon-Exon Junctions to the mRNA Surveillance Machinery by the Protein RNPS1 , 2001, Science.
[68] D. Gabuzda,et al. ERK MAP Kinase Links Cytokine Signals to Activation of Latent HIV-1 Infection by Stimulating a Cooperative Interaction of AP-1 and NF-κB* , 1999, The Journal of Biological Chemistry.
[69] D. Richman,et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.
[70] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[71] G. Nolan,et al. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. , 1997, Immunity.
[72] C. Van Lint,et al. Transcriptional activation and chromatin remodeling of the HIV‐1 promoter in response to histone acetylation. , 1996, The EMBO journal.
[73] G. Nabel,et al. An inducible transcription factor activates expression of human immunodeficiency virus in T cells , 1987, Nature.
[74] A. Abate,et al. Rapid Encapsulation of Cell and Polymer Solutions with Bubble‐Triggered Droplet Generation , 2017 .
[75] Alberto Bosque,et al. Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. , 2009, Blood.